🇺🇸 FDA

Intelligence Platform

Patents

Browse 35 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12263169

Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulat

Corcept Therapeutics Incorporated · Granted Tue Apr 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12202841

Therapeutic agents for enhancing epithelial and/or endothelial barrier function

INSTITUTE FOR STEM CELL SCIENCE AND REGENERATIVE MEDICINE · Granted Tue Jan 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11890340

Use of epithelial membrane protein 2 [EMP2] targeting agents in treating lung disorders

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Feb 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11793810

Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulat

Corcept Therapeutics Incorporated · Granted Tue Oct 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11213526

Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulat

Corcept Therapeutics Incorporated · Granted Tue Jan 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11186873

Combination method for treating cancer by targeting immunoglobulin superfamily member 1 (I

Wellmarker Bio Co., LTD. · Granted Tue Nov 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11149253

Small molecule compound combination for reprogramming digestive tract derived epithelial c

INSTITUTE OF TRANSFUSION MEDICINE, ACADEMY OF MILITARY MEDICAL SCIENCES, PEOPLE'S LIBRATION ARMY OF CHINA · Granted Tue Oct 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11083708

Pharmacological restoration of epithelial or endothelial barrier integrity by agents block

The Regents of the University of California · Granted Tue Aug 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10722523

Chemoimmunotherapy for epithelial cancer

The Regents of the University of California · Granted Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10663473

Method of identifying a status of a mucosal intestinal epithelial barrier to improve treat

Maximus Diagnostic Technologies LLC · Granted Tue May 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10329353

Specific detection tool for mesenchymal and epithelial-mesenchymal transformed circulating

The Board of Regents of the University of Texas System · Granted Tue Jun 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10034916

Methods of treating a retinal disease by retinal pigment epithelial stem cells

REGENERATIVE RESEARCH FOUNDATION · Granted Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9624304

Antibodies which bind to epithelial membrane protein 2 (EMP2)

The Regents of the University of California · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9464135

Epithelial membrane protein-2 (EMP2) and proliferative vitroretinopathy (PVR)

THE UNITED STATES OF AMERICA DEPARTMENT OF VETERAN AFFAIRS · Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8748176

Generation of choroid plexus epithelial cells from human embryonic stem cells

The Regents of the University of California · Granted Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8481313

Retinal pigment epithelial stem cells

REGENERATIVE RESEARCH FOUNDATION · Granted Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8343481

Method of preparing lung alveolar epithelial type II cells derived from embryonic stem cel

The Board of Regents of the University of Texas System · Granted Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8198254

Annexin A9 (ANXA9) biomarker and therapeutic target in epithelial cancer

The Regents of the University of California · Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8030012

Id-1 and Id-2 genes and products as markers of epithelial cancer

The Regents of the University of California · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7824695

Delivery of proteins across polar epithelial cell layers

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7429457

Id-1 and Id-2 genes and products as markers of epithelial cancer

The Regents of the University of California · Granted Tue Sep 30 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7125969

ETS-related gene overexpressed in human breast and epithelial cancers

The Regents of the University of California · Granted Tue Oct 24 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7026291

Epithelial cell specific growth factor, keratinocyte growth factor (KGF)

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Apr 11 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6982168

Immortal human prostate epithelial cell lines and clones and their applications in the res

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 03 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired